<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="168">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05158959</url>
  </required_header>
  <id_info>
    <org_study_id>IRB NO.527/62</org_study_id>
    <nct_id>NCT05158959</nct_id>
  </id_info>
  <brief_title>Association Between Renal Reserve Function and Progression of Renal Function to Predict CKD Risk in Thai Elderly</brief_title>
  <official_title>Study of the Association Between Renal Reserve Function and Progression of Renal Function to Predict Chronic Kidney Disease Risk in Thai Elderly</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates renal functional reserve in elderly.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prevalence of CKD in elder is high as age has been a variable in eGFR equation. eGFR by&#xD;
      calculation always declines in parallel with age. The assumption that a persistent over 3&#xD;
      months of eGFR less than 60 mL/min/1.73m2 define CKD with risk of progression and need refer&#xD;
      to nephrologist may not necessary true in aging population. We study renal functional reserve&#xD;
      in elderly population who risk of CKD progression and ESRD is the highest prevalence in human&#xD;
      life cycle and explore whether renal functional reserve can be used as ad additional marker&#xD;
      of CKD progression in elderly.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 24, 2019</start_date>
  <completion_date type="Anticipated">December 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Change of renal functional reserve per 12 months (mL/min)</measure>
    <time_frame>12 months</time_frame>
    <description>Renal functional reserve defined as the difference between baseline creatinine clearance and creatinine clearance achieved under stimulation with amino acid infusion.</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Elder</condition>
  <condition>Renal Function Abnormal</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Elders age more than 60 years who are non-frail and has no limited life expectancy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient age &gt; 60 years at screening&#xD;
&#xD;
          -  Patient willing to participate in the study and can provide inform consent&#xD;
&#xD;
          -  Patient have residual kidney function â‰¤ 90 ml/min/1.73m2 by CKD-EPI equation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient active smoking&#xD;
&#xD;
          -  Patient have Charlson comorbidity index &gt; .....&#xD;
&#xD;
          -  Patient active cancer&#xD;
&#xD;
          -  Patient contraindications for blood collection&#xD;
&#xD;
          -  Patients with a history of hypersensitivity to cimetidine or amino acid IV solution&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kearkiat Praditpornsilpa</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kearkiat Praditpornsilpa, MD</last_name>
      <phone>6602564251</phone>
      <email>kearkiat@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>December 2, 2021</study_first_submitted>
  <study_first_submitted_qc>December 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 15, 2021</study_first_posted>
  <last_update_submitted>December 2, 2021</last_update_submitted>
  <last_update_submitted_qc>December 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chulalongkorn University</investigator_affiliation>
    <investigator_full_name>Kearkiat Praditpornsilpa</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Renal functional reserve, CKD progression, Elderly</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease Progression</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

